Vida Vafaizadeh

Georg Speyer Haus — Germany

Medicine · Health Sciences

19h-index1.3kcitations41works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(19), Cytokine Signaling Pathways and Interactions(10), Cancer, Hypoxia, and Metabolism(8), Cancer-related molecular mechanisms research(6), Cancer-related Molecular Pathways(6)

Publications41 total

Correction: Weber et al. Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells. Cancers 2015, 7, 503–537
Cancers·2025Open Access
Supplementary Figure S2 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S1 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S4 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Data from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S3 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S1 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S3 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S4 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Data from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
Supplementary Figure S2 from Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
2023Open Access
A microfluidic Braille valve platform for on-demand production, combinatorial screening and sorting of chemically distinct droplets
Nature Protocols·2022· 21 citedOpen Access
The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis
Oncogene·2021· 26 citedOpen Access
Parsing β-catenin’s cell adhesion and Wnt signaling functions in malignant mammary tumor progression
Proceedings of the National Academy of Sciences·2021· 35 citedOpen Access
Editorial: Perspectives in Mammary Gland Development and Breast Cancer Research
Frontiers in Cell and Developmental Biology·2020· 3 citedOpen Access
Immuno-Oncology Biomarkers for Personalized Immunotherapy in Breast Cancer
Frontiers in Cell and Developmental Biology·2020· 30 citedOpen Access
The Eleventh ENBDC Workshop: Advances in Technology Help to Unveil Mechanisms of Mammary Gland Development and Cancerogenesis
Journal of Mammary Gland Biology and Neoplasia·2019· 3 cited
Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma
Cancer Research·2015· 64 citedOpen Access
Expression of the mi<scp>R</scp>‐302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes
International Journal of Cancer·2015· 37 citedOpen Access
Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells
Cancers·2015· 20 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Bernd Groner(32), Christian Schmithals(11), Verena Köberle(11), Hüdayi Korkusuz(11), Thomas Pleli(11), Bianca Kakoschky(11), Eduardo Alonso Augusto(11), Ahmed Atef Ibrahim(11), José M. Arencibia(11), Horst‐Werner Korf(11), Bernd Kronenberger(11), Stefan Zeuzem(11), Thomas J. Vogl(11), Oliver Waidmann(11), Albrecht Piiper(11), Petra Klemmt(7), Boris Brill(6), Corina Borghouts(5), Natalia Delis(5), Christian Brendel(4)